+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor Antigen"

Bispecific Antibodies Market - Global Forecast to 2030 - Product Thumbnail Image

Bispecific Antibodies Market - Global Forecast to 2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
T-Cell Immunotherapy Market - Global Forecast 2025-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Dual Targeted Therapy Market - Global Forecast 2025-2030 - Product Thumbnail Image

Dual Targeted Therapy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Targeted Therapy Market - Global Forecast 2025-2030 - Product Thumbnail Image

Targeted Therapy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Combination Antibody Therapy Market - Global Forecast 2025-2030 - Product Thumbnail Image

Combination Antibody Therapy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
CAR T-cell Therapy Market - Global Forecast to 2030 - Product Thumbnail Image

CAR T-cell Therapy Market - Global Forecast to 2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Oncolytic Virus Therapies Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oncolytic Virus Therapies Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Immunotherapy Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Antitumor ADC Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Antitumor ADC Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
CAR-T Cell Service Market - Global Forecast 2025-2030 - Product Thumbnail Image

CAR-T Cell Service Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
From
Cancer Immunotherapy Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cancer Immunotherapy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
From
Cancer Immunotherapy Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Cancer Immunotherapy Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Bi-Specific MAbS Market Report 2025 - Product Thumbnail Image

Bi-Specific MAbS Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
T-Cell Therapy Market - Global Forecast 2025-2030 - Product Thumbnail Image

T-Cell Therapy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
CAR T-cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025 - Product Thumbnail Image

Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 450 Pages
  • Global
From
Hyperthermia Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Hyperthermia Cancer Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 384 Pages
  • Global
From
Loading Indicator

The Tumor Antigen market is a subset of the Oncology Drugs market, which focuses on the development of drugs to treat cancer. Tumor antigens are molecules that are expressed on the surface of cancer cells and can be recognized by the immune system. These antigens can be used to develop drugs that target and destroy cancer cells, while leaving healthy cells unharmed. Tumor antigens can be used to develop vaccines, monoclonal antibodies, and other immunotherapies. These therapies can be used to treat a variety of cancers, including breast, lung, and colorectal cancer. Some companies in the Tumor Antigen market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are actively researching and developing new treatments for cancer, including immunotherapies that target tumor antigens. Show Less Read more